Cite
MLA Citation
Sara Pai et al.. “354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A216. http://access.bl.uk/ark:/81055/vdc_100144728481.0x000005